Left ventricular remodeling in premature ventricular contraction-induced cardiomyopathy: Effect of coupling intervals

Pouria Shoureshi1,2, Rajiv Kabadi1, Nicholas James2

  • 1Department of Internal Medicine, Cardiology Division, Central Virginia VA Health Care System/McGuire Veterans Affairs Medical Center, Richmond, Virginia.

Heart Rhythm O2
|September 25, 2023
PubMed

Insights

Short-coupled and long-coupled premature ventricular contractions (PVCs) both contribute equally to PVC-induced cardiomyopathy (PVC-CM) through left ventricular dyssynchrony and postextrasystolic potentiation. Atrioventricular dissociation did not independently influence PVC-CM development.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Research

Background:

  • Premature ventricular contractions (PVCs) can lead to cardiomyopathy (PVC-CM).
  • Left ventricular dyssynchrony (LVD) and postextrasystolic potentiation (PESP) are implicated in PVC-CM development.
  • Long-coupled (LC) PVCs induce greater LVD, while short-coupled (SC) PVCs exhibit stronger PESP.

Purpose of the Study:

  • To compare SC-PVCs and LC-PVCs.
  • To evaluate the roles of LVD, PESP, and atrioventricular dissociation (AVD) in PVC-CM development.

Main Methods:

  • Canine model with induced bigeminal PVCs (50% burden) for 12 weeks.
  • Grouping into SC-PVC, LC-PVC, and sham control groups.
  • Monitoring of PVC burden, AVD, echocardiographic changes, and hemodynamics.

Main Results:

  • Both SC-PVC and LC-PVC groups showed significant decreases in left ventricular ejection fraction (LVEF) compared to sham.
  • PVC burden was similar between groups, but higher in SC-PVC.
  • No significant correlation found between AVD and LVEF reduction.

Conclusions:

  • Neither PVC coupling interval nor AVD independently determined PVC-CM severity.
  • LVD and PESP contribute equally to PVC-CM development.
  • This study elucidates the mechanisms of PVC-induced cardiomyopathy.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
15
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14